首页 正文

Compliance with the RSV immunoprophylaxis dosing schedule in the Polish registry for palivizumab (2008-2014)

{{output}}
Objective: Background: Respiratory syncytial virus infection causes respiratory diseases in about 90% of the children under 2 years of age. Currently the only way to prevent infection is through immunoprophylaxis based on paliviz... ...